Special ReportsAll NewsFDA BriefsOncology IconsThe Targeted PulseVoices from the Field
Conference CoverageConference ListingData Dialogue with the Oncology Brothers
All VideosCase-Based Peer PerspectivesEvolving Paradigms in OncologyExpert Perspective Virtual Tumor BoardInterviewsInvestigator PerspectivesMedical World NewsPersonalized MedicinePivotal Practice Views with the Oncology BrothersPodcastsSpeaking Out
All PublicationsEvolving ParadigmsPeers & Perspectives in OncologyTargeted Therapies in Oncology
CASE-BASED ROUNDTABLEPARTNERS
CME/CEClinical TrialsEventsPrecision Medicine PerspectivesPress ReleasesSponsored ContentTreatment Resources
SUBSCRIBE
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
Spotlight -
  • Biomarker-Driven Lung Cancer
  • GIST
  • HER2 Breast Cancer
  • Chronic Lymphocytic Leukemia
  • Small Cell Lung Cancer
  • Renal Cell Carcinoma
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
    • CASE-BASED ROUNDTABLE
    • PARTNERS
    • SUBSCRIBE
Advertisement

Metastatic Prostate Cancer with Charles Ryan, MD and William K. Oh, MD: Case 1

home / case-based-peer-perspectives / mcrpc-oh-ryan-case-1

Metastatic Prostate Cancer with Charles Ryan, MD and William K. Oh, MD


Charles Ryan, MD: Biggest Considerations for Elderly Patient Population

EP. 1: Charles Ryan, MD: Biggest Considerations for Elderly Patient Population

July 14th 2016

Watch


William Oh, MD: Biggest Considerations for Elderly Patient Population

EP. 2: William Oh, MD: Biggest Considerations for Elderly Patient Population

July 14th 2016

Watch


Charles Ryan, MD: Treatment Options and Favorable Approaches for an Elderly Patient

EP. 3: Charles Ryan, MD: Treatment Options and Favorable Approaches for an Elderly Patient

July 14th 2016

Watch


Charles Ryan, MD: The Differences in Side Effects Between the Two AR-Targeted Therapies

EP. 4: Charles Ryan, MD: The Differences in Side Effects Between the Two AR-Targeted Therapies

July 14th 2016

Watch


Charles Ryan, MD: The Efficacy of Abiraterone Plus Prednisone in an Elderly Patient Population

EP. 5: Charles Ryan, MD: The Efficacy of Abiraterone Plus Prednisone in an Elderly Patient Population

July 14th 2016

Watch


Charles Ryan, MD: The Side Effects for Prednisone in Combination With Abiraterone

EP. 6: Charles Ryan, MD: The Side Effects for Prednisone in Combination With Abiraterone

July 14th 2016

Watch


William Oh, MD: Ideal Treatment Options and Favorable Approaches

EP. 7: William Oh, MD: Ideal Treatment Options and Favorable Approaches

July 14th 2016

Watch


William Oh, MD: Differences Between Side Effects of AR-Targeted Therapies

EP. 8: William Oh, MD: Differences Between Side Effects of AR-Targeted Therapies

July 14th 2016

Watch


William Oh, MD: The Efficacy of Abiraterone Plus Prednisone in an Elderly Patient Population

EP. 9: William Oh, MD: The Efficacy of Abiraterone Plus Prednisone in an Elderly Patient Population

July 14th 2016

Watch


William Oh, MD: The Side Effects of Prednisone in Combination with Abiraterone

EP. 10: William Oh, MD: The Side Effects of Prednisone in Combination with Abiraterone

July 14th 2016

Watch

About Us
Advertise
Contact Us
CureToday.com
CancerNetwork.com
OncLive.com
OncNursingNews.com
Do Not Sell My Information
Privacy
Terms & Conditions
Editorial Board
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.